GRAB

GRAB CEO and COO Buy $30.7M in Shares on Open Market

Chief Executive Anthony Tan and President and COO Alexander Hungate together bought about 10.65 million Grab shares near $2.89 on the same day.

Source: Wikimedia

Two of the most senior executives at Grab Holdings (GRAB) bought stock on the open market on 21 September 2026, in transactions worth roughly $30.7 million combined. Both purchases were disclosed in Form 4 filings with the Securities and Exchange Commission on the same day, making this a clustered insider buy rather than two unrelated moves.

A utility-scale solar farm of the type planned under the Tadaa and Kainan partnership.

TREASURE GLOBAL (TGL) Unit Joins $367M, 360 MW Malaysian Solar Farm Project

Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.

A natural gas wellhead of the kind found across Pennsylvania's Marcellus shale.

ALPHA COMPUTE (ALP) Buys 300 Acres of Pennsylvania Gas Land for $5.5M

Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.

Palisade Bio is developing an oral prodrug aimed at inflammatory bowel disease.

FDA Clears PALISADE BIO IND for PALI-2108 in Crohn's Disease

Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.

PDS Biotechnology is seeking a partner to fund Phase 3 development of its HPV16-targeted immunotherapy PDS0101.

PDS (PDSB) BIOTECH Phase 2 Data Published in JAMA Oncology With 39.3-Month Survival

VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.

Read more

TREASURE GLOBAL (TGL) Unit Joins $367M, 360 MW Malaysian Solar Farm Project

ALPHA COMPUTE (ALP) Buys 300 Acres of Pennsylvania Gas Land for $5.5M

FDA Clears PALISADE BIO IND for PALI-2108 in Crohn's Disease

PDS (PDSB) BIOTECH Phase 2 Data Published in JAMA Oncology With 39.3-Month Survival